Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease

Research output: Contribution to journalArticle

Abstract

Background Basophil activation has been implicated in the pathogenesis of aspirin-exacerbated respiratory disease (AERD). However, a comprehensive analysis of basophil responses to aspirin in terms of mediator release, cytokine secretion and increased expression of surface activation markers has not been performed. Objective To study the in vitro effects of aspirin on the concurrent release of histamine, leukotriene C4 (LTC4) and IL-4 from human basophils and to also evaluate changes in surface activation markers (CD63, CD69 and CD203c) expressed by these cells. Methods Basophil-enriched cell suspensions from 10 patients with AERD and 10 healthy volunteers were incubated with lysine-aspirin for up to 3 h. Cells were analysed for expression of CD63, CD69 and CD203c using flow cytometry. Cell-free supernatants were evaluated for histamine, and LTC4 release and for IL-4 secretion. Results Aspirin-induced expression of CD63, CD69 and CD203c yielded 30%, 80% and 70% sensitivity, respectively, but with poor specificity. There was no significant difference in LTC4 synthesis between groups. None of the patients with AERD (or controls) released IL-4 in response to aspirin. A higher dose of 5 mg/mL aspirin-mediated non-specific effects on basophils. Conclusion Basophil responses to in vitro aspirin challenge are poor indicators of clinical sensitivity. Aspirin activates some basophils by means of mechanisms that differ from the classical IgE-mediated pathway. Our study also shows that the use of 27 mm of aspirin (5 mg/mL) by previous investigators causes non-specific basophil activation, thereby eliminating its usefulness in a cell-based diagnostic test for AERD. Evaluation of in vitro basophil activation has low clinical value in identifying aspirin-induced respiratory reactions.

Original languageEnglish (US)
Pages (from-to)1522-1531
Number of pages10
JournalClinical and Experimental Allergy
Volume39
Issue number10
DOIs
StatePublished - Oct 2009

Fingerprint

Basophils
Aspirin
Leukotriene C4
Interleukin-4
In Vitro Techniques
Histamine Release
Routine Diagnostic Tests
Immunoglobulin E
Histamine
Suspensions
Healthy Volunteers
Flow Cytometry

Keywords

  • Aspirin
  • Aspirin-exacerbated respiratory disease
  • Asthma
  • Basophil
  • CD203c
  • CD63
  • CD69
  • Flow cytometry
  • Histamine
  • Leukotriene C

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

@article{da989e3bb509417980d353097274cf35,
title = "Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease",
abstract = "Background Basophil activation has been implicated in the pathogenesis of aspirin-exacerbated respiratory disease (AERD). However, a comprehensive analysis of basophil responses to aspirin in terms of mediator release, cytokine secretion and increased expression of surface activation markers has not been performed. Objective To study the in vitro effects of aspirin on the concurrent release of histamine, leukotriene C4 (LTC4) and IL-4 from human basophils and to also evaluate changes in surface activation markers (CD63, CD69 and CD203c) expressed by these cells. Methods Basophil-enriched cell suspensions from 10 patients with AERD and 10 healthy volunteers were incubated with lysine-aspirin for up to 3 h. Cells were analysed for expression of CD63, CD69 and CD203c using flow cytometry. Cell-free supernatants were evaluated for histamine, and LTC4 release and for IL-4 secretion. Results Aspirin-induced expression of CD63, CD69 and CD203c yielded 30{\%}, 80{\%} and 70{\%} sensitivity, respectively, but with poor specificity. There was no significant difference in LTC4 synthesis between groups. None of the patients with AERD (or controls) released IL-4 in response to aspirin. A higher dose of 5 mg/mL aspirin-mediated non-specific effects on basophils. Conclusion Basophil responses to in vitro aspirin challenge are poor indicators of clinical sensitivity. Aspirin activates some basophils by means of mechanisms that differ from the classical IgE-mediated pathway. Our study also shows that the use of 27 mm of aspirin (5 mg/mL) by previous investigators causes non-specific basophil activation, thereby eliminating its usefulness in a cell-based diagnostic test for AERD. Evaluation of in vitro basophil activation has low clinical value in identifying aspirin-induced respiratory reactions.",
keywords = "Aspirin, Aspirin-exacerbated respiratory disease, Asthma, Basophil, CD203c, CD63, CD69, Flow cytometry, Histamine, Leukotriene C",
author = "{\cC}elik, {G. E.} and Schroeder, {John Thomas} and Hamilton, {Robert G} and Saini, {Sarbjit S} and Adkinson, {N Franklin}",
year = "2009",
month = "10",
doi = "10.1111/j.1365-2222.2009.03277.x",
language = "English (US)",
volume = "39",
pages = "1522--1531",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease

AU - Çelik, G. E.

AU - Schroeder, John Thomas

AU - Hamilton, Robert G

AU - Saini, Sarbjit S

AU - Adkinson, N Franklin

PY - 2009/10

Y1 - 2009/10

N2 - Background Basophil activation has been implicated in the pathogenesis of aspirin-exacerbated respiratory disease (AERD). However, a comprehensive analysis of basophil responses to aspirin in terms of mediator release, cytokine secretion and increased expression of surface activation markers has not been performed. Objective To study the in vitro effects of aspirin on the concurrent release of histamine, leukotriene C4 (LTC4) and IL-4 from human basophils and to also evaluate changes in surface activation markers (CD63, CD69 and CD203c) expressed by these cells. Methods Basophil-enriched cell suspensions from 10 patients with AERD and 10 healthy volunteers were incubated with lysine-aspirin for up to 3 h. Cells were analysed for expression of CD63, CD69 and CD203c using flow cytometry. Cell-free supernatants were evaluated for histamine, and LTC4 release and for IL-4 secretion. Results Aspirin-induced expression of CD63, CD69 and CD203c yielded 30%, 80% and 70% sensitivity, respectively, but with poor specificity. There was no significant difference in LTC4 synthesis between groups. None of the patients with AERD (or controls) released IL-4 in response to aspirin. A higher dose of 5 mg/mL aspirin-mediated non-specific effects on basophils. Conclusion Basophil responses to in vitro aspirin challenge are poor indicators of clinical sensitivity. Aspirin activates some basophils by means of mechanisms that differ from the classical IgE-mediated pathway. Our study also shows that the use of 27 mm of aspirin (5 mg/mL) by previous investigators causes non-specific basophil activation, thereby eliminating its usefulness in a cell-based diagnostic test for AERD. Evaluation of in vitro basophil activation has low clinical value in identifying aspirin-induced respiratory reactions.

AB - Background Basophil activation has been implicated in the pathogenesis of aspirin-exacerbated respiratory disease (AERD). However, a comprehensive analysis of basophil responses to aspirin in terms of mediator release, cytokine secretion and increased expression of surface activation markers has not been performed. Objective To study the in vitro effects of aspirin on the concurrent release of histamine, leukotriene C4 (LTC4) and IL-4 from human basophils and to also evaluate changes in surface activation markers (CD63, CD69 and CD203c) expressed by these cells. Methods Basophil-enriched cell suspensions from 10 patients with AERD and 10 healthy volunteers were incubated with lysine-aspirin for up to 3 h. Cells were analysed for expression of CD63, CD69 and CD203c using flow cytometry. Cell-free supernatants were evaluated for histamine, and LTC4 release and for IL-4 secretion. Results Aspirin-induced expression of CD63, CD69 and CD203c yielded 30%, 80% and 70% sensitivity, respectively, but with poor specificity. There was no significant difference in LTC4 synthesis between groups. None of the patients with AERD (or controls) released IL-4 in response to aspirin. A higher dose of 5 mg/mL aspirin-mediated non-specific effects on basophils. Conclusion Basophil responses to in vitro aspirin challenge are poor indicators of clinical sensitivity. Aspirin activates some basophils by means of mechanisms that differ from the classical IgE-mediated pathway. Our study also shows that the use of 27 mm of aspirin (5 mg/mL) by previous investigators causes non-specific basophil activation, thereby eliminating its usefulness in a cell-based diagnostic test for AERD. Evaluation of in vitro basophil activation has low clinical value in identifying aspirin-induced respiratory reactions.

KW - Aspirin

KW - Aspirin-exacerbated respiratory disease

KW - Asthma

KW - Basophil

KW - CD203c

KW - CD63

KW - CD69

KW - Flow cytometry

KW - Histamine

KW - Leukotriene C

UR - http://www.scopus.com/inward/record.url?scp=70349091376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349091376&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2222.2009.03277.x

DO - 10.1111/j.1365-2222.2009.03277.x

M3 - Article

C2 - 19486029

AN - SCOPUS:70349091376

VL - 39

SP - 1522

EP - 1531

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 10

ER -